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Abstract
Despite the important role of T cell activation in the adaptive immunity, very little is known about the functions of
proteins that are differentially expressed in the activated Tc e l l s .I nt h i ss t u d y ,w eh a v ee m p l o y e dp r o t e o m i ca p p r o a c ht o
study the differentially expressed proteins in activated T cells. A total of 25 proteins was characterized that displayed a
decreased expression, while a total of 20 proteins was characterized that displayed an increased expression in the
activated T cells. Among them, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was identified unexpectedly as one
of the up-regulated proteins. Western blot analysis of proteins separated by 2-dimensional gel electrophoresis had
identified several modified GAPDHs which were detectable only in the activated T cells, but not in resting T cells. These
modified GAPDHs had higher molecular mass and more basic PI, and were present in the nucleus of activated T cells.
Promoter occupancy studies by chromatin immunoprecipitation assay revealed that nuclear GAPDH could be detected in
the promoter of genes that were up-regulated during T cell activation, but not in the promoter of genes that were not
unaffected or down-regulated. Our results suggest that nuclear GAPDH may function as transcriptional regulator in
activated T cells.
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Introduction
T lymphocytes, a key player in adaptive immunity, regulate all
immune responses by interacting with antigen and by secreting
cytokines. In a typical T cell immune response, the antigen
presented by major histocompatibility complex is recognized by
the T cell receptor to activate T cells [1]. Two major events occur
in T cell activation, one is T cell proliferation (also called clonal
expansion) to increase the number of antigen-specific T cells and
the other is T cell differentiation, which transforms activated T
cells into either memory cells or effectors.
T cell activation is known to mediate through complex signaling
pathways that result in the expression and/or down-regulation of
genes which are important for the physiological functions of the
activated T cells [1–3]. Despite the important role of T cell
activation in the adaptive immunity, very little is known
concerning about the functions of proteins that are differentially
expressed in the activated T cells. Two dimensional electropho-
resis (2-DE) and mass spectrometry have been successfully used to
analyze the protein expression pattern of lymphocytes, e.g.,
proteomic map of lymphoblastoid proteins [4], differentiation
patterns of human Th1 and Th2 cells [5] and anti-CD3/anti-
CD28 antibody-activated T helper cells [6]. As yet, none of these
studies has attempted to examine the proteins that are differen-
tially expressed in the activated T cells. In this study, we employed
proteomic approach to investigate the proteins that are differen-
tially expressed in the activated T cells.
Methods
Cell culture
The use of peripheral blood to cultivate T lymphocytes was
reviewed and approved by institutional review board and ethics
committee of Chang Gung Memorial Hospital. Informed written
consent was obtained from healthy blood donors at Hsin-Chu
Blood Centre, Taiwan. The peripheral blood lymphocytes (PBL)
were isolated and cultured as previously described [7]. Activation
of T cells was done by cultivating PBL in the presence of
phytohemagglutinin (PHA) at 5 mg/ml.
Two-dimensional electrophoresis (2-DE)
Proteins were extracted from cultured cells with a lysis solution
containing 8 M urea, 4% CHAPS, 40 mM Tris-HCL, pH 8.0 and
1 mM PMSF, and were stored at 280uC prior to use. Separation
of proteins in the first dimension was performed using the
IPGphor
TMIEF system (Amersham Pharmacia Biotech). Briefly,
150 mg of proteins was mixed with 180 ml of rehydration solution
containing 8 M urea, 2% CHAPS, 0.5% IPG buffer (pI 4–7 or 6–
10 from Amersham Pharmacia Biotech.) and trace amounts of
bromophenol blue. The mixtures were then applied onto 13 cm
Immobiline Dry Strips (pI 4–7 or pI 6–10). After rehydrating the
strips at 30 V, 12 h, the strips were electro- focused for 0.5 h at
50 V, 0.5 h at 100 V, 0.5 h at 250 V, 0.5 h at 500 V, 0.5 h at
1000 V, 0.5 h at 4000 V and 8 h at 8000 V. After focusing, the
strips were first equilibrated in an equilibration buffer (6 M urea,
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65 mM DTT, and then in an equilibration buffer containing
53 mM iodoacetamide. For second dimensional separation, the
equilibrated strips were placed onto 10% or 12% polyacrylamide
gel containing 0.2% SDS and electrophoresed at 20 mA/gel for
4 h. The proteins in the gel were identified by silver staining [8].
Analysis of proteins by MALDI-TOF MS
Protein spots of interest were excised from the gel separated by
2-DE, and washed with 25 mM NH4HCO3 containing 50%
acetonitril for 15 min. The excised gels were next destained by a
solution that contains 30 mM potassium ferricyanide and 200 mM
sodium thiosulfate, and washed with 25 mM NH4HCO3. The gels
were dehydrated by 100% acetonitril and dried. The proteins in
the dried gel were digested with trypsin (20 mg/ml) for 8 h at
37uC. The digested peptide fragments were isolated by sonication
for 10 min in 40% acetonitril that contains 0.4% trifluroacetic
acid. For the identification of protein by matrix-assisted laser
desorption/ionization-time of flight mass spectrometry (MALDI-
TOF MS) and/or TOF/TOF, the peptide spectra of protein were
calibrated against standard peptides derived from angiotensin II
and adrenocorticotropic hormone (ACTH) and the database
search was performed with Mascot (http://www.matrixscience.
com) program using NCBI and SWISS-PROT databases.
Western blot
Analysis of proteins by Western blot was essentially the same as
previously described [9]. The anti-GAPDH was obtained from
Abcam Limited, Cambridgeshire, UK.
RNA extraction and RT-PCR
Total RNA from cells was extracted by TRIzol isolateion
reagent (Invitrogen) following manufacturer’s instruction. The
conditions for RT-PCR were essentially the same as previously
described [7]. The sequences of the primers used in the RT-PCR
for the identification of various genes were listed in Table 1.
Chromatin immunoprecipitation (ChIP) assay
The occupancy of GAPDH in the promoter of various genes
was assayed by chromatin immunoprecipitation (ChIP) assay as
described previously [9]. In brief, the PHA-treated PBL were
suspended in RPMI 1640 medium containing 1% formaldehyde
(10
6 cells/ml), and incubated at 37uC for 10 min. The crosslinking
reaction was stopped by adding glycine to a final concentration of
0.125 M and the cells were collected by centrifugation. After
washing twice with cold phosphate buffer saline (PBS) containing
10 mM PMSF and protease inhibitor cocktail (Sigma), the cell
pellets were resuspended in SDS lysis solution (1% SDS, 10 mM
EDTA, 50 mM Tris-HCl, pH 8.0) containing protease inhibitors,
and incubated on ice for 10 min. To shear DNA, the cell lysates
were sonicated on ice by 3 rounds of 10-second pulse at 7% output
power in a sonicator (W-380, Heat systems-Ultrasonics Inc.). After
sonication, the samples were centrifuged at 14,000 rpm for
10 min, and the supernatants were collected. To reduce non-
specific background, the supernatants were diluted 10-fold with a
dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA,
16.7 mM Tris-HCl, pH 8.0, 167 mM NaCl) containing protease
inhibitors and Protein A Agarose/Salmon Sperm DNA (Upstate/
Millipore Corp.). After mixing at 4uC for 1 h, the mixtures were
centrifuged at 1,000 rpm for 1 min to obtain pre-cleared
Table 1. The sequence of primers used in RT-PCR and ChIP.
Gene RT-PCR primers ChIP primers
hTERT LT5:5 9-CGGAAGACTGTCTGGAGCAA PF:5 9-TGCCCCTTCACCTTCCAG
LT6:5 9-GGATGAAGCGGA GTCTGG A PR:5 9-CAGCGCTGCCTGAAACTC
cMyc F:5 9-AGAGTCTGGATCACCTTCTGCTGG PF:5 9-TCGAGAAGGGCAGGGCTT
R:5 9-ACGGACAGGATGTATGCTGTGG PR:5 9-TGCCTCTCGCTGGAATTA
GAPDH WW144:5 9-TGGTATCGTGGAA PF:5 9-TACTAGCGGTTT
GGACTCATGAC TACGGGCG
WW145:5 9-TGCCAGTGAG PR:5 9-TCGAACAGGAGG
CTTCCCGTTCAGC. AGCAGAGAGCGA
B23 F:5 9-TTGTTGAAGCAGAGGCAATG PF:5 9-AAGCATGGGCCTGCTTGTTG
R:5 9-ACTTCCTCCACTGCCAGAGA PR:5 9-GAGAGCTGCCATCACAGTAC
Cx3CR1 F:5 9-TGACTGGCAGATCCAGAGGTT PF:5 9-ATGAGCTCTCCCAGCTTCCT
R:5 9-GTAGAATATGGACAGGAACAC PR:5 9-ATCTTTAGATGCTGCCACAGG
H2B F:5 9-AGACGGCAAGAAGCGCAAGCG PF:59-GGATTTGCGAAT
R:5 9- GCCAGGCGGGAAGCCTCACCT CCTGATTGGGCA
PR:5 9-AGCACTGTGTAG
CTATAAAGCGCC
PKC b1 F:5 9-GACCATGGACCGCCTGTACTTTG PF:5 9-ATCCCATTGGTCATTCTGCA
R:5 9-GAAGAACAGACCGATGGCAAT PR:5 9-GATCTACTGAAATCCTTCCTC
PKC d F:5 9-CTGCAAGAAGAACAATGGCAAG PF:5 9-ATCCAAGGAATGGGCGAGCTC
R:5 9-ATCCACGTCCTCCAGGAAATACT PR:5 9-CCTCAGGGAAGCCTTTCCGAG
b-actin F:5 9-TGTATGCCTCTGGTCGTACCAC PF:5 9-CATTTAGCTAGCTGAGCCCCA
R:5 9-ACAGAGTACTTGCGCTCAGGAG PR:5 9-TGTGGACATCTCTTGGGCACT
doi:10.1371/journal.pone.0006322.t001
Nuclear GAPDH in T Cells
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supernatant and mixed at 4uC overnight. The antibody/protein/
DNA complex was immunoprecipitated by adding Protein A
Agarose/Salmon Sperm DNA with rotation at 4uC for 1 h, and
pelleted by centrifugation. The immunoprecipitated complex was
washed for 4 min on a rotating platform with 4 ml each of the
buffers listed in the following order: (i) Low salt wash buffer (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0,
150 mM NaCl); (ii) High salt wash buffer (0.1% SDS, 1% Triton
X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0, 500 mM NaCl);
(iii) LiCl wash buffer (250 mM LiCl, 1% NP-40, 1% sodium
deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.0); and (iv)
TE buffer (10 mM Tric-HCl, pH 8.0, 1 mM EDTA). After
washing, the protein/DNA complex was eluted from the
immunoprecipitates by incubation in 500 ml of elution buffer
(1% SDS, 0.1 M NaHCO3) at room temperature for 15 min
twice. To reverse the formaldehyde crosslinks of protein/DNA
complex, 40 ml of 5 M NaCl was added to the combined eluate
(1000 ml) and incubated at 65uC for 4 h. After incubating with
protease K (40 mg/ml) at 45uC for 1 h, the DNA in the solution
was extracted by phenol/chloroform and collected by ethanol
precipitation. The primers used for the detection of antibody-
bound chromatin DNA in the promoter of different genes were
listed in Table 1.
Immunoflurorescence confocal microscopy
Cells were fixed with 4% paraformadehyde in a slide and then
permeabilized in PBS containing 0.1% Triton X-100 for 10 min
at room temperature. The permeabilized cells were then
incubated with a blocking solution (PBS containing 0.1% Triton
X-100 and 5 mg/ml of bovine albumin) for 20 min to minimize
the background staining. To detect GAPDH in the fixed cells, the
rabbit anti-human GADPH antibody was added to the cells and
incubated for 1 h. After washing the cells three times with PBS
containing 0.1% Triton X-100, goat anti-rabbit IgG antibody
conjugated with FITC was then added and incubated for another
45 min at room temperature. Finally, the cells were washed and
coverslide was mounted onto the slide in Vectashield mounting
medium containing DAPI (Vector Laboratories, H-100). Immu-
nofluorescence analyses were performed with Leica TCS SP2
confocal laser scanning microscope (Leica Microsystems Inc.,
Germany) using 1006objective lens at 0.4 mm intervals.
Results
Differentially expressed proteins in the PHA-treated PBL
To investigate the proteins that are differentially expressed in
activated T cells, PBL were stimulated with PHA and the proteins
from the treated cells were separated by 2-DE. Representative 2-
DE results of the proteins electro-focused for pI 4–7 and pI 6–11
in the 1st dimension were shown in Fig. 1. The protein spots,
which displayed at least 2-fold increase or decrease from the
untreated controls, were operationally defined in this study as the
differentially expressed proteins. A total of 48 protein spots
displayed a decrease (Fig. 1A and B), whereas a total of 36 spots
displayed an increase (Fig. 1C and D) in the activated T cells. The
identity of these differentially expressed proteins was analyzed by
MALDI-TOF and/or TOF/TOF, and the results were summa-
rized in Table S1.
To facilitate the analysis, the identified proteins were grouped
according to their known biochemical functions: cytoskeleton,
metabolism, protein destination, or others. Since many of protein
spots contain peptide sequence of the same protein, a total of 25
characterized proteins were shown to decrease in the activated cells.
These proteins include 10 cytoskeleton related proteins (TPMsk1,
vinculin, b5-tubulin, c-actin, talin, fibrinogen c-A chain precursor,
fibrinogen c chain, tropomyosin TM30-pl, a-actinin 1, and cofilin),
4 protein-destination related proteins (ubiquitous tropomodulin,
heat shock cognate protein 54, protein disulfide-isomerase ER60
precursor, and DnaK-type molecular chaperone), 4 metabolism-
related proteins (triosephosphate isomerase, pyruvate kinase 3,
glyceraldehyde-3-phosphate dehydrogenase, and carbonate dehy-
dratase II), and 7 were unclassified (hypothetical protein
AAH17450, 14-3-3 protein zeta, sorcin, RNA-binding protein
regulatory subunit, Mn-superoxide dismutase, transgelin 2, hypo-
thetical protein FLJ34571) (Table S1). On the other hand, a total of
20 proteins were characterized to increase in the activated cells.
These proteins include 3 cytoskeleton-related proteins (hematopoi-
etic lineage cell-specific protein HS1, macrophage capping protein,
and cofilin), 6 protein-destination related proteins (cathepsin D,
cathepsin B precursor, 26S proteasome chain p453, proteasome
subunit a type 2, peptidyl-prolyl cis-trans isomerase A, and 40S
ribosomal protein S12), 5 metabolism-related proteins (pyruvate
dehydrogenase E1-b subunit precursor, fumarate hydratase pre-
cursor, phosphoglycerate kinase 1, fructose-bisphosphate aldolase
A, and glyceraldehyde-3-phosphate dehydrogenase) and 6 unclas-
sified proteins (B23 nucleophosmin, aryl hydrocarbon receptor-
interacting protein-like 2, hnRNP protein A2, sequence 49 from
Patent WO0102600, Mn-superoxide dismutase, and mitochondrial
Mn-superoxide dismutase) (Table S1).
Multiple forms of GAPDH in resting and activated T cells
Among the many differentially expressed proteins identified in
the activated T cells, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was unique in that it’s detected in many different
locations on the 2-D gels (B6, B12, B14 in Fig. 1B; D6, D7, D8
and D9 in Fig. 1D) and was detected both as an increased and
decreased protein (Table S1). Since GAPDH has been thought as
a housekeeping gene and is commonly used as an internal control
in the RT-PCR analysis of gene expression, our identification of
GAPDH as a differentially expressed protein in the activated T
cells (Fig. 1B & D, and Table S1) was rather unexpected. We have
confirmed that the level of GAPDH mRNA was rather constant in
both unstimulated and activated T cells (7, and data not shown).
Therefore, the increased GAPDH protein spots observed in the
activated T cells (Fig. 1D) is likely attributed to a post-
transcriptional mechanism. The molecular weight (M.W.) of
protein in spots B12 and B14 are considerably smaller than the
predicted M. W. of intact GAPDH and, therefore, may represent
degraded forms of GAPDH. While the protein in B6, B12 and B14
spots in the resting T cells displayed a decrease in the activated T
cells, the protein in spots D6, D7, D8 and D9 was increased and
present only in the activated T cells. To confirm that the protein in
these spots is indeed GAPDH, the area of 2-D gel containing spots
B6, D6, D7, D8 and D9 was sliced (boxed rectangle in Fig. 2) and
subjected to Western blot analysis by anti-GAPDH antibody. As
shown in the bottom panels of Fig. 2, three low M. W. spots were
detected in both resting and activated T cells, whereas the high
M.W. smear containing the spots D6, D7, D8 and D9 was
detected only in the PHA-activated T cells, indicating that
GAPDH may exist in different modified forms in T cells.
Cellular location of GAPDHs in activated T cells
Although GAPDH is a key enzyme in glycolysis which is known
to take place in cytoplasm, it has been shown that GAPDH has
different cellular locations in non-cycling or cycling cells [10,11].
To gain further insights about the function of modified GAPDHs
in the activated T cells, the cellular locations of these modified
Nuclear GAPDH in T Cells
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extracts were separated by 2-DE and the area of gel containing
spots B6, D6, D7, D8 and D9 was sliced (boxed rectangle as shown
in Fig. 2) and subjected to Western blot analysis by anti-GAPDH
antibody. As shown in Fig. 3A, the three low M.W. protein spots of
GAPDH (as pointed by arrows in Fig. 3A) were detected in the
total cell extracts, but not in the nuclear extracts from resting and
activated T cells. On the other hand, the high M.W. protein spots
circled in Fig. 3A were detected in the nuclear and total cell
extracts of activated T cells, but not from the resting cells.
Therefore, it appears that the low M.W. GAPDHs are cytosolic
and function both in the resting and activated T cells, whereas the
high M.W. GAPDHs are detected only in the activated T cells. To
confirm that GAPDH indeed can locate in the nucleus of activated
T cells, the cellular location of GAPDHs was further examined by
confocal microscopy. Resting and activated T cells were fixed by
paraformaldehyde, and the distribution of GAPDH was detected
by in situ staining with anti-GAPDH antibody. As shown in Fig. 3B,
it was clear that GAPDH was present only in the cytoplasm of
resting T cells, but was readily detected both in the cytoplasm and
nucleus of activated T cells. While none of the resting T cells was
positive for nuclear GAPDH staining, 77% and 100% of PBL
activated by PHA for 24 and 48 h, respectively, was positive for
nuclear GAPDH staining. Together, these results indicate that the
GAPDH was post-translationally modified during T cell activation
and the modified GAPDHs (protein spots D6–9 of Fig. 1D) could
translocate to the nucleus of activated T cells.
The transcriptional function of nuclear GAPDH
Our detection of nuclear GAPDH in activated T cells raises the
question for cellular functions of these nuclear GAPDH. In
addition to its enzymatic role in glycolysis, GAPDH has been
Figure 1. Identification of proteins that are differentially expressed in the activated T cells. Activation of T cells was done by cultivating
PBL in the presence of PHA at 5 mg/ml for 1–3 days. The protein extracts from untreated controls (panels A and B) or PHA-treated cells (panels C and
D) were electro-focused in a pH 4–7 (panels A and C) or in a pH 6–11 (panels B and D) IPG strip for the 1
st dimension and then separated in a 10%
SDS-PAGE for the 2
nd dimension. The protein spots that displayed at least 2-fold increase or decrease were marked by arrow in panels A–D, and
referred to A1-33, B1-15, C1-15, D1-21, respectively. The identities of these proteins were analyzed by MALTI-TOF and TOF/TOF, and the results were
summarized in Table S1.
doi:10.1371/journal.pone.0006322.g001
Nuclear GAPDH in T Cells
PLoS ONE | www.plosone.org 4 July 2009 | Volume 4 | Issue 7 | e6322reported to participate in proliferation, apoptosis [12,13], telomere
protection [14], and transcription [11,15]. To investigate whether
the nuclear GAPDH may participate in the regulation of gene
expression during T cell activation, the promoter occupancy by
GAPDH was examined using chromatin immunoprecipitation
(ChIP) method. The candidate genes that we selected for this study
include the genes that are up-regulated (eg., hTERT, cMyc, B23
and histone H2B) [9,15], down-regulated (eg., CX3CR1 and PKC
b1) [16], or unaffected (eg., PKC d and a2actin) [17] during T
cell activation. As shown in Fig. 4A, we have confirmed, in
general, that these genes were either up-regulated or down-
regulated as previously reported. Interestingly, GAPDH was
readily detected in the promoters of hTERT, cMyc, B23 and
H2B genes, but not in the CX3CR1, PKC b1, PKC d,o ra2actin
genes (Fig. 4B).
Discussion
In this work, we have employed proteomic approach to identify
the differentially expressed proteins in PHA-activated T cells. A
total of 25 proteins was characterized that displayed a decreased
expression, while a total of 20 proteins was characterized that
displayed an increased expression in the activated T cells (Table
S1). These differentially expressed proteins, in theory, may arise
from altered gene expression, protein modification, degradation,
or changes in protein stability. Among the proteins that displayed
a decreased expression, a majority of them were cytoskeleton-
related proteins, such as tropomyosin, tublin, a-actinin, talin, and
viculin. These proteins are involved in the shape of cells,
movement, and communication with extracellular environment
through integrins [18,19]. While the mRNA synthesis of these
proteins was not examined, Western blot analysis of talin and
viculin revealed multi forms of these proteins with lower molecular
mass (data not shown). Decreased gene expression coupled with
protein degradation is likely to account for the observed decrease
of these proteins in the activated T cells.
A total of 20 proteins were characterized to increase in the
activated cells.Althoughthe increased expressionoftheseproteinsis
likely resulted from transcriptional up-regulation, altered expression
ofproteinwithconstantrate ofmRNA synthesishasbeenpreviously
observed in several studies [5,20,21]. We have noted that several
differentiallyexpressed proteinshadmultiforms with different M.W.
and/or PI. Example for proteins having same M.W. but different
PIs was B23 (C10, 11 and 12 in Fig. 1C). Examples for proteins
having different M.W. and PIs were cofilin (B15 in Fig. 1B and D18
in Fig. 1D), hnRNP A2 (D10, 11 and 12 in Fig. 1D), and GAPDH
(B6, B12, B14 in Fig. 1B and D6, 7, 8 and 9 in Fig. 1D). It is likely
that these multiforms represent post-translational modification.
Although not tested in this study, the different charges carried by
these proteins may be caused by phosphorylation, since phosphor-
ylated forms of these proteins have been observed and are known to
modulate the protein activity [11,22,23].
Among the proteins that displayed an increased expression,
GAPDH is unique in that it’s detected in many different locations
on the 2-D gels and was detected also as a protein with decreased
expression. Although GAPDH is known for its key enzyme activity
in glycolysis, several recent studies have revealed that GAPDH is a
multifunction protein which may participate in proliferation,
apoptosis [12,13], telomere protection [14], and transcription
[11,15], suggesting that this protein may reside in the various
intracellular localizations in order to perform these functions
[24,25]. Here, we demonstrated that GAPDH indeed may exist in
different modified forms in T cells (Fig. 2). The three low M.W.
Figure 2. Detection of GAPDH by Western blot. The protein extracts from untreated control (left panel) or PHA-treated cells (right panel) were
electro-focused in a pH 6-11 IPG strip for the 1
st dimension and then separated in a 10% SDS-PAGE for the 2
nd dimension. The area of 2-D gel
containing putative GAPDH spots (boxed rectangle) was sliced out and subjected to Western blot analysis with anti-GAPDH antibody as shown in the
bottom.
doi:10.1371/journal.pone.0006322.g002
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detected in the total lysates, but not in the nuclear extracts from
resting and activated T cells, indicating that these forms are
cytosolic. On the other hand, the high M.W. protein spots as
circled in Fig. 3A were detected in the nucleus of activated T cells.
This result is in agreement with finding that GAPDH is localized
primarily in the cytoplasm of non-cycling cells, but an increased
amount of GAPDH is detected in the nucleus of cycling cells [26].
To address the function of nuclear GAPDH in activated T cells,
we asked whether GAPDH may participate in transcription
Figure 3. Cellular locations of GAPDHs in resting and activated T cells. (A) Total cell extract and nuclear extract were prepared from resting
and PHA-activated PBL. The proteins in the extracts were separated by 2-DE, and the area of 2-D gel containing putative GAPDH spots was sliced out
and subjected to Western blot analysis with anti-GAPDH antibody. (B) Resting and PHA-activated T cells were fixed and immunostained with anti-
GAPDH antibody in situ. Immunofluorescence analyses were performed with a confocal laser scanning microscope. The location of GAPDH is
indicated by green fluorescence whereas the nucleus is indicated by blue.
doi:10.1371/journal.pone.0006322.g003
Nuclear GAPDH in T Cells
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the expression of histone 2B (H2B) [15]. The occupancy of
GAPDH in the promoter of various genes in vivo was analyzed by
ChIP. Interestingly, GAPDH was detected in the promoters of
several genes which displayed an increased expression in the
activated T cells, but not in the promoters of genes that were
unaffected or down-regulated (Fig. 4). Although the molecular
mechanism by which GAPDH may bind to the promoter is not
known at present, our finding for a preferential occupancy of
GAPDH in the up-regulated genes suggests that nuclear GAPDH
may participate in transcriptional regulation in the activated T
cells.
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